Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19
The novel coronavirus infection (COVID-19) caused by the b-coronavirus SARS-CoV-2, and leads to acute respiratory distress-syndrome, has affected more than nineteen million people worldwide, resulting in 0.7 million deaths as of August 2020. The fact that the virus uses angiotensin-converting enzyme...
Saved in:
Main Authors: | Irina E. Chazova, Natalia V. Blinova, Vera A. Nevzorova, Juliya V. Zhernakova, Mikhail P. Savenkov, Elena V. Oshchepkova, Olga D. Ostroumova, Oksana A. Kisliak, Sergey A. Boytsov |
---|---|
Format: | article |
Language: | RU |
Published: |
IP Morozov P.V.
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/55789dfd3a7c47e795bff6a70e7febd7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hiperaldosteronismo primario y embarazo: Lecciones obtenidas de 2 casos clínicos
by: Germain A,Alfredo M, et al.
Published: (2002) -
Menores niveles tisulares de la enzima convertidora de angiotensina I homologa (ECA-2) y angiotensina-(1-9) están asociados a mayor remodelamiento de la pared aórtica de ratas hipertensas
by: Ocaranza,María Paz, et al.
Published: (2010) -
Tactics of antihypertensive therapy during COVID-19 pandemic
by: Valery I. Podzolkov, et al.
Published: (2021) -
Actividad de 11 beta hidroxiesteroide dehidrogenasa tipo 2 en hipertensos chilenos
by: Mosso G,Lorena, et al.
Published: (2002) -
Relationship between the expression of angiotensin II receptors type 1 and vasoactive regulators in arterial hypertension
by: Anna V. Logatkina, et al.
Published: (2020)